Search Results - "Kerschbaumer, J"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Serious tumor seeding after brainstem biopsy and its treatment—a case report and review of the literature by Pinggera, D., Kvitsaridtze, I., Stockhammer, G., Eisner, W., Thomé, C., Freyschlag, C. F., Moser, P., Kerschbaumer, J.

    Published in Acta neurochirurgica (01-04-2017)
    “…Stereotactic brain biopsies for histopathological diagnosis are a common technique in case of intracranial lesions, particularly in those not amenable for…”
    Get full text
    Journal Article
  7. 7

    SP 10. Innsbruck experience in neuropathic pain syndromes: Re-think and re-construct old methods for better results by Eisner, W, Sohm, F, Rehwald, R, Scharnboeck, L, Siedentopf, C, Quirbach, S, Gizewski, E, Kerschbaumer, J

    Published in Clinical neurophysiology (01-09-2016)
    “…Introduction In the last 25 years neuromodulation by deep brain stimulation gained widely acceptance starting in the field of movement disorders and getting…”
    Get full text
    Journal Article
  8. 8

    Evaluating the Performance of Small Wastewater Treatment Plants by Engstler, Eva, Kerschbaumer, David J., Langergraber, Guenter

    Published in Frontiers in environmental science (15-07-2022)
    “…An evaluation of the treatment performance of small wastewater treatment plants with the capacity of ≤50 PE (population equivalent) was carried out using data…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Preoperative prediction of language function by diffusion tensor imaging by Freyschlag, C. F., Kerschbaumer, J., Pinggera, D., Bodner, T., Grams, A. E., Thomé, C.

    Published in Brain informatics (01-09-2017)
    “…For surgery of eloquent tumors in language areas, the accepted gold standard is functional mapping through direct cortical stimulation (DCS) in awake patients…”
    Get full text
    Journal Article
  11. 11

    Optimization of an Antibody Light Chain Framework Enhances Expression, Biophysical Properties and Pharmacokinetics by Douillard, Patrice, Freissmuth, Michael, Antoine, Gerhard, Thiele, Michael, Fleischanderl, Daniel, Matthiessen, Peter, Voelkel, Dirk, Kerschbaumer, Randolf J., Scheiflinger, Friedrich, Sabarth, Nicolas

    Published in Antibodies (Basel) (06-09-2019)
    “…Efficacy, safety, and manufacturability of therapeutic antibodies are influenced by their biopharmaceutical and biophysical properties. These properties can be…”
    Get full text
    Journal Article
  12. 12

    Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic by Rossmueller, Gregor, Mirkina, Irina, Maurer, Barbara, Hoeld, Verena, Mayer, Julia, Thiele, Michael, Kerschbaumer, Randolf J, Schinagl, Alexander

    Published in Molecular cancer therapeutics (04-05-2023)
    “…High levels of macrophage migration inhibitory factor (MIF) in patients with cancer are associated with poor prognosis. Its redox-dependent conformational…”
    Get full text
    Journal Article
  13. 13

    Targeting of oxidized Macrophage Migration Inhibitory Factor (oxMIF) with antibody ON104 attenuates the severity of glomerulonephritis by Ferhat, Maroua, Mayer, Julia, Costa, Lyndon H, Prendecki, Maria, Tarazona, Alejandro A Puchol, Schinagl, Alexander, Kerschbaumer, Randolf J, Tam, Frederick W K, Landlinger, Christine, Thiele, Michael

    Published in PloS one (07-10-2024)
    “…The oxidized form of Macrophage Migration Inhibitory Factor (oxMIF) has been identified as the disease-related isoform of MIF, exerting pathological functions…”
    Get full text
    Journal Article
  14. 14

    Role of the Cysteine 81 Residue of Macrophage Migration Inhibitory Factor as a Molecular Redox Switch by Schinagl, Alexander, Kerschbaumer, Randolf J, Sabarth, Nicolas, Douillard, Patrice, Scholz, Peter, Voelkel, Dirk, Hollerweger, Julia C, Goettig, Peter, Brandstetter, Hans, Scheiflinger, Friedrich, Thiele, Michael

    Published in Biochemistry (Easton) (06-03-2018)
    “…Macrophage migration inhibitory factor (MIF) is a pro-inflammatory and tumor-promoting cytokine that occurs in two redox-dependent immunologically distinct…”
    Get full text
    Journal Article
  15. 15

    Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer by Schinagl, Alexander, Thiele, Michael, Douillard, Patrice, Völkel, Dirk, Kenner, Lukas, Kazemi, Zahra, Freissmuth, Michael, Scheiflinger, Friedrich, Kerschbaumer, Randolf J

    Published in Oncotarget (08-11-2016)
    “…Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine, which was shown to be upregulated in cancers and to exhibit tumor promoting properties…”
    Get full text
    Journal Article
  16. 16
  17. 17

    P09.44 One year with Optune in Austria: First report on clinical experiences by Pinggera, D., Kerschbaumer, J.

    Published in Neuro-oncology (Charlottesville, Va.) (01-05-2017)
    “…Objective: Tumor Treating Fields (TTFields) consist of intermediate frequency alternating electric fields that are delivered through 4 transducer arrays,…”
    Get full text
    Journal Article
  18. 18

    An Antibody Specific for Coagulation Factor IX Enhances the Activity of the Intrinsic Factor X-activating Complex by Kerschbaumer, Randolf J., Riedrich, Klaudia, Kral, Martina, Varadi, Katalin, Dorner, Friedrich, Rosing, Jan, Scheiflinger, Friedrich

    Published in The Journal of biological chemistry (24-09-2004)
    “…During hemostasis the zymogen factor X (FX) is converted into its enzymatically active form factor Xa by the intrinsic FX-activating complex. This complex…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Single-Chain Fv Fusion Proteins Suitable as Coating and Detecting Reagents in a Double Antibody Sandwich Enzyme-Linked Immunosorbent Assay by Kerschbaumer, Randolf J., Hirschl, Sonja, Kaufmann, Andrea, Ibl, Martin, Koenig, Renate, Himmler, Gottfried

    Published in Analytical biochemistry (01-07-1997)
    “…A recombinant enzyme-linked immunosorbent assay (ELISA) system, entirely based on antibody fragments, is described here as an attractive alternative to assays…”
    Get full text
    Journal Article